Labotoxico SA
Labotoxico reported total assets of €4.05m at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Jan 2026).
The score of Labotoxico shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -10 % Total assets +12 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Labotoxico's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 26 Jan 2026
- Year ended 30 Jun 2024filed on 27 Jan 2025
- Year ended 30 Jun 2023filed on 30 Jan 2024
- Year ended 30 Jun 2022filed on 31 Jan 2023
- Year ended 30 Jun 2021filed on 27 Jan 2022
Labotoxico's financial analysis
- Solvency61.2%sector median: 47.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Labotoxico
Labotoxico's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0432.685.722
- VAT number
- BE0432685722
- Peppol
- Registered · 0208:0432685722 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Nov 1987
- Registered office
- 8340 Damme
- Latest accounts
- 2025 · filed on 26 Jan 2026
- Activity
- Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses (NACE 47741)
Labotoxico (SA) has been based in Damme since 1987, active in: retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses. For 2025, it reports a net loss of 28,201 € and equity of €2.48m; its revenue is not published. Its solvency stands at 61.2%, above the median of its sector (47.8%).
Companies similar to Labotoxico
Companies in the same business, of comparable size and area, outside its group.
- Spentys Manufacture of medical and dental instruments and supplies Forest · balance sheet €3.99m
- Dynamic Retail sale of medical and orthopaedic goods Ostend · balance sheet €3.46m
- Sprotech Manufacture of medical and dental instruments and supplies Sint-Niklaas · balance sheet €3.36m
- Euromi Manufacture of medical and dental instruments and supplies Dison · balance sheet €5.14m
- Medical Robots Manufacture of medical and dental instruments and supplies Geel · balance sheet 66,424 €
- AGC Audio Retail sale of medical and orthopaedic goods Brussels · balance sheet €3.36m
- 2enjoy Retail sale of medical and orthopaedic goods Oudenaarde · balance sheet 298 €
- Visicon Retail sale of medical and orthopaedic goods Alken · balance sheet €4.06m
Frequently asked questions about Labotoxico
What is the revenue of Labotoxico?
Labotoxico files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Labotoxico?
In Belgium, the VAT number is the company number prefixed with BE: BE0432685722 for Labotoxico, if the company is VAT-registered. Its company number (CBE) is 0432.685.722.
Where is the registered office of Labotoxico?
According to the CBE register, the registered office of Labotoxico is in 8340 Damme.
What is the equity of Labotoxico?
At the close of the 2025 financial year, the equity of Labotoxico amounts to 2,479,599 €, a solvency of 61.2% of total assets.
Who manages Labotoxico?
The register lists 4 active mandates at Labotoxico. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Labotoxico
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →